As MGL binding was related to a higher frequency of lymph node metastasis, we also determined whether high MGL binding was associated with a decreased disease-specific survival of patients within the SCC/ASC group. This evidence concerns the gene CLEC10A and metastatic malignant neoplasm in the lymph nodes.